Skip to main content
OpenTrials

Clinical trial condition

Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma

Explore clinical trials studying Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

6 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma trial results

Recruiting

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

NCT03011814

Conditions
Folliculotropic Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma

NCT01035463

Conditions
Anaplastic Large Cell Lymphoma, ALK-negative, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • University of Kansas Hospital-Westwood Cancer Center Westwood, Kansas, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details

Related conditions